453 related articles for article (PubMed ID: 17950326)
21. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
[TBL] [Abstract][Full Text] [Related]
22. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis.
Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G
Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040
[TBL] [Abstract][Full Text] [Related]
23. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.
Bea F; Kreuzer J; Preusch M; Schaab S; Isermann B; Rosenfeld ME; Katus H; Blessing E
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2787-92. PubMed ID: 16990551
[TBL] [Abstract][Full Text] [Related]
24. A preparation of herbal medicine Salvia miltiorrhiza reduces expression of intercellular adhesion molecule-1 and development of atherosclerosis in apolipoprotein E-deficient mice.
Ling S; Dai A; Guo Z; Komesaroff PA
J Cardiovasc Pharmacol; 2008 Jan; 51(1):38-44. PubMed ID: 18209567
[TBL] [Abstract][Full Text] [Related]
25. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
Matsui R; Xu S; Maitland KA; Mastroianni R; Leopold JA; Handy DE; Loscalzo J; Cohen RA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):910-6. PubMed ID: 16439706
[TBL] [Abstract][Full Text] [Related]
26. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
[TBL] [Abstract][Full Text] [Related]
28. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
[TBL] [Abstract][Full Text] [Related]
29. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
[TBL] [Abstract][Full Text] [Related]
30. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion.
Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX
J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574
[TBL] [Abstract][Full Text] [Related]
31. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
[TBL] [Abstract][Full Text] [Related]
32. COX-2 expression in chondrosarcoma: a role for celecoxib treatment?
Schrage YM; Machado I; Meijer D; Briaire-de Bruijn I; van den Akker BE; Taminiau AH; Kalinski T; Llombart-Bosch A; Bovée JV
Eur J Cancer; 2010 Feb; 46(3):616-24. PubMed ID: 20004565
[TBL] [Abstract][Full Text] [Related]
33. BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase.
Cherdon C; Rolin S; Hanson J; Ooms A; de Leval L; Drion P; Michiels C; Pirotte B; Masereel B; Sakalihassan N; Defraigne JO; Dogné JM
Prostaglandins Other Lipid Mediat; 2011 Apr; 94(3-4):124-32. PubMed ID: 21397034
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
Yao R; Cheng X; Liao YH; Chen Y; Xie JJ; Yu X; Ding YJ; Tang TT
J Cardiovasc Pharmacol; 2008 Feb; 51(2):188-95. PubMed ID: 18287887
[TBL] [Abstract][Full Text] [Related]
35. Increased ICAM-1 and PECAM-1 transcription levels in the heart of Apo-E deficient mice in comparison to wild type (C57BL6).
Zibara K; Chettab K; McGregor B; Poston R; McGregor J
Thromb Haemost; 2001 May; 85(5):908-14. PubMed ID: 11372687
[TBL] [Abstract][Full Text] [Related]
36. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
Zhang LN; Vincelette J; Cheng Y; Mehra U; Chen D; Anandan SK; Gless R; Webb HK; Wang YX
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1265-70. PubMed ID: 19667112
[TBL] [Abstract][Full Text] [Related]
40. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
